Treatment of the later stages of Parkinson’s disease – pharmacological approaches now and in the future
出版年份 2015 全文链接
标题
Treatment of the later stages of Parkinson’s disease – pharmacological approaches now and in the future
作者
关键词
Rasagiline, Entacapone, Rotigotine, Motor Complication, Dopaminergic Medication
出版物
Translational Neurodegeneration
Volume 4, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-06-18
DOI
10.1186/2047-9158-4-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- 'Don't delay, start today': delaying levodopa does not delay motor complications
- (2014) S. H. Fox et al. BRAIN
- The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa
- (2014) R. Cilia et al. BRAIN
- Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease
- (2014) R. A. Hauser et al. EUROPEAN JOURNAL OF NEUROLOGY
- Therapeutic strategies to prevent and manage dyskinesias in Parkinson’s disease
- (2014) Manuela Pilleri et al. Expert Opinion On Drug Safety
- Pharmacological Treatment of Parkinson Disease
- (2014) Barbara S. Connolly et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Transdermal rotigotine in advanced Parkinson’s disease: a randomized, double-blind, placebo-controlled trial
- (2014) Masahiro Nomoto et al. JOURNAL OF NEUROLOGY
- Sleep Disorders in Parkinsonian Macaques: Effects of L-Dopa Treatment and Pedunculopontine Nucleus Lesion
- (2014) H. Belaid et al. JOURNAL OF NEUROSCIENCE
- Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
- (2014) Stéphane Palfi et al. LANCET
- Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial
- (2014) PD MED Collaborative Group LANCET
- The expanding universe of disorders of the basal ganglia
- (2014) Jose A Obeso et al. LANCET
- Novel formulations and modes of delivery of levodopa
- (2014) Werner Poewe et al. MOVEMENT DISORDERS
- Clinical spectrum of levodopa-induced complications
- (2014) Camila Catherine Aquino et al. MOVEMENT DISORDERS
- Comparison of IPX066 with carbidopa–levodopa plus entacapone in advanced PD patients
- (2014) Fabrizio Stocchi et al. PARKINSONISM & RELATED DISORDERS
- Sustained efficacy of apomorphine in Japanese patients with advanced Parkinson's disease
- (2014) Nobutaka Hattori et al. PARKINSONISM & RELATED DISORDERS
- Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias
- (2014) Olivier Rascol et al. PARKINSONISM & RELATED DISORDERS
- Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications
- (2014) M. Angela Cenci Frontiers in Neurology
- Pharmacological Treatments Inhibiting Levodopa-Induced Dyskinesias in MPTP-Lesioned Monkeys: Brain Glutamate Biochemical Correlates
- (2014) Nicolas Morin et al. Frontiers in Neurology
- Non-dopaminergic Treatments for Motor Control in Parkinson’s Disease
- (2013) Susan H. Fox DRUGS
- The adverse event profile of perampanel: meta-analysis of randomized controlled trials
- (2013) G. Zaccara et al. EUROPEAN JOURNAL OF NEUROLOGY
- Treatment of motor fluctuations in Parkinson’s disease: recent developments and future directions
- (2013) Adolfo Ramirez-Zamora et al. Expert Review of Neurotherapeutics
- Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson’s disease experiencing mild wearing-off: a randomised, double-blind trial
- (2013) Eduardo Tolosa et al. JOURNAL OF NEURAL TRANSMISSION
- Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial
- (2013) Jeffrey Cummings et al. LANCET
- Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
- (2013) C Warren Olanow et al. LANCET NEUROLOGY
- Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease
- (2013) Stewart A. Factor et al. MOVEMENT DISORDERS
- Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations
- (2013) Rupam Borgohain et al. MOVEMENT DISORDERS
- Adenosine A2Areceptor antagonist istradefylline reduces daily OFF time in Parkinson's disease
- (2013) Yoshikuni Mizuno et al. MOVEMENT DISORDERS
- AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study
- (2013) Fabrizio Stocchi et al. MOVEMENT DISORDERS
- Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease
- (2013) C. Warren Olanow et al. MOVEMENT DISORDERS
- D1 receptor agonist improves sleep–wake parameters in experimental parkinsonism
- (2013) Carole Hyacinthe et al. NEUROBIOLOGY OF DISEASE
- Withdrawing amantadine in dyskinetic patients with Parkinson disease: The AMANDYSK trial
- (2013) F. Ory-Magne et al. NEUROLOGY
- Treatment of Cognitive, Psychiatric, and Affective Disorders Associated with Parkinson’s Disease
- (2013) Barbara Connolly et al. Neurotherapeutics
- Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease
- (2013) Amaal AlDakheel et al. Neurotherapeutics
- Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease
- (2013) Rajesh Pahwa et al. PARKINSONISM & RELATED DISORDERS
- Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens
- (2013) F. Mancini et al. PARKINSONISM & RELATED DISORDERS
- Early DEtection of wEaring off in Parkinson disease: The DEEP study
- (2013) F. Stocchi et al. PARKINSONISM & RELATED DISORDERS
- Promises of novel multi-target neuroprotective and neurorestorative drugs for Parkinson's disease
- (2013) Moussa B.H. Youdim et al. PARKINSONISM & RELATED DISORDERS
- Perampanel in Parkinson Disease Fluctuations
- (2012) Olivier Rascol et al. CLINICAL NEUROPHARMACOLOGY
- Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson's disease
- (2012) A. H. V. Schapira et al. EUROPEAN JOURNAL OF NEUROLOGY
- Novel nondopaminergic targets for motor features of Parkinson's disease: Review of recent trials
- (2012) Lorraine V. Kalia et al. MOVEMENT DISORDERS
- Alpha-synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficits
- (2012) Penelope J. Hallett et al. NEUROBIOLOGY OF DISEASE
- Animal models of the non-motor features of Parkinson's disease
- (2012) Kimberly McDowell et al. NEUROBIOLOGY OF DISEASE
- Depression and anxiety related subtypes in Parkinson's disease
- (2011) R. G. Brown et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial
- (2011) Robert A Hauser et al. LANCET NEUROLOGY
- Perampanel, an AMPA antagonist, found to have no benefit in reducing “off” time in Parkinson's disease
- (2011) Andrew Lees et al. MOVEMENT DISORDERS
- The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease
- (2011) Pablo Martinez-Martin et al. MOVEMENT DISORDERS
- Milestones in Parkinson's disease-Clinical and pathologic features
- (2011) Glenda Halliday et al. MOVEMENT DISORDERS
- AFQ056 treatment of levodopa-induced dyskinesias: Results of 2 randomized controlled trials
- (2011) Daniela Berg et al. MOVEMENT DISORDERS
- Parkinson’s disease: The non-motor issues
- (2011) K. Ray Chaudhuri et al. PARKINSONISM & RELATED DISORDERS
- Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction
- (2010) N. Pavese et al. BRAIN
- When Do Levodopa Motor Fluctuations First Appear in Parkinson’s Disease
- (2010) Fabrizio Stocchi et al. EUROPEAN NEUROLOGY
- Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial
- (2010) Murat Emre et al. LANCET NEUROLOGY
- Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo-controlled study
- (2010) Karla Eggert et al. MOVEMENT DISORDERS
- Clinical efficacy of istradefylline (KW-6002) in Parkinson's disease: A randomized, controlled study
- (2010) Yoshikuni Mizuno et al. MOVEMENT DISORDERS
- Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures
- (2010) M. Politis et al. NEUROLOGY
- Characterization of the Potent and Highly Selective A2A Receptor Antagonists Preladenant and SCH 412348 [7-[2-[4-2,4-Difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in Rodent Models of Movement Disorders and Depression
- (2009) R. A. Hodgson et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
- (2009) K Ray Chaudhuri et al. LANCET NEUROLOGY
- Adenosine, adenosine A2A antagonists, and Parkinson's disease
- (2009) P. Jenner et al. PARKINSONISM & RELATED DISORDERS
- Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia
- (2008) A. Munoz et al. BRAIN
- Relationship between weight, levodopa and dyskinesia: the significance of levodopa dose per kilogram body weight
- (2008) J. C. Sharma et al. EUROPEAN JOURNAL OF NEUROLOGY
- Non-dopaminergic treatments in development for Parkinson's disease
- (2008) Susan H Fox et al. LANCET NEUROLOGY
- Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations
- (2008) Robert A. Hauser et al. MOVEMENT DISORDERS
- Molecular mechanisms of L-DOPA-induced dyskinesia
- (2008) Peter Jenner NATURE REVIEWS NEUROSCIENCE
- Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD
- (2008) R. Katzenschlager et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now